Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Key Trends
1.3. Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1. Rheumatology Therapeutics Market, by Disease Type, 2016-2026 (USD Billion)
1.3.2. Rheumatology Therapeutics Market, by Drug Type, 2016-2026 (USD Billion)
1.3.3. Rheumatology Therapeutics Market, by Distribution Channel, 2016-2026 (USD Billion)
1.3.4. Rheumatology Therapeutics Market, by Region, 2016-2026 (USD Billion)
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Rheumatology Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Rheumatology Therapeutics Market Dynamics
3.1. See Saw Analysis
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Rheumatology Therapeutics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.2. PEST Analysis
4.2.1. Political Scenario
4.2.2. Economic Scenario
4.2.3. Social Scenario
4.2.4. Technological Scenario
4.3. Key Buying Criteria (On Demand)
4.4. Regulatory Framework (On Demand)
4.5. Investment Vs Adoption Scenario (On Demand)
4.6. Analyst Recommendation & Conclusion
Chapter 5. Rheumatology Therapeutics Market, by Disease Type
5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Key Market Players
5.4. Rheumatology Therapeutics Market, Sub Segment Analysis
5.4.1. Rheumatoid Arthritis
5.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.2. Ankylosing Spondylitis
5.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.3. Osteoarthritis
5.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.4. Lupus
5.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.5. Gout
5.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.4.6. Others
5.4.6.1. Market estimates & forecasts, 2016-2026 (USD Billion)
5.4.6.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6. Rheumatology Therapeutics Market, by Drug Type
6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Key Market Players
6.4. Rheumatology Therapeutics Market, Sub Segment Analysis
6.4.1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
6.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.2. Analgesics
6.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.3. Disease Modifying Anti-Rheumatic Drugs (DMARDs)
6.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.4. Corticosteroids
6.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.4.5. Others
6.4.5.1. Market estimates & forecasts, 2016-2026 (USD Billion)
6.4.5.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7. Rheumatology Therapeutics Market, by Distribution Channel
7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Key Market Players
7.4. Rheumatology Therapeutics Market, Sub Segment Analysis
7.4.1. Retail Pharmacy
7.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2. Online Pharmacy
7.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3. Hospitals
7.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4. Others
7.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2. Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8. Rheumatology Therapeutics Market, by Regional Analysis
8.1. Rheumatology Therapeutics Market, Regional Market Snapshot (2016-2026)
8.2. North America Rheumatology Therapeutics Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.1.4. Distribution Channels breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.2.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3. Europe Rheumatology Therapeutics Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.3.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4. Asia Rheumatology Therapeutics Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.3.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.4.4.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5. Latin America Rheumatology Therapeutics Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.5.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6. Rest of The World
8.6.1. South America
8.6.1.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.1.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2. Middle East and Africa
8.6.2.1. Market estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.2. Disease Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.3. Drug Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
8.6.2.4. Distribution Channel breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. AbbVie
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Summary
9.3.1.4. Recent Developments
9.3.2. Pfizer
9.3.3. Bristol-Myers Squibb Company
9.3.4. Merck & Co.
9.3.5. Amgen
9.3.6. Janssen Biotech
9.3.7. Novartis AG
9.3.8. Genentech
9.3.9. Takeda Pharmaceutical
9.3.10. Sanofi
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.1.6. Research Assumption